What’s New at Diapharma?
Posted: October 3, 2017
Meet Matt Sobo
Matt joined DiaPharma in March of 2017 as a Technical Specialist and is, therefore, the New Guy. Matt earned his degree in Biology from Lafayette College and Master’s Degrees in molecular and cellular biology from The Ohio State University. He spent six years at Cincinnati Children’s Hospital Medical Center researching aggressive pediatric brain cancers before joining Diapharma.
Matt, along with his wife and daughter, are guests in the house of their 2 cats—Bean and Fry Man—and are awaiting the arrival of their second child in a few short weeks. Matt enjoys reading good books, current events and politics, corny Dad Jokes, and unmitigated disasters such as the New York Mets.
Meet us at The Liver Meeting®
Visit booth # 543 to learn the latest news on M30/keratin 18 (K18) biomarkers and more. Visit Diapharma to discuss mechanistic biomarkers that can provide important biological information ongoing in the liver.
Caspase – Cleaved Keratin 18
(ccK18: M30 ELISA)
(cleaved and uncleaved: M65 ELISA)
Hepatocyte apoptosis and necrosis
Hyaluronic Acid (HA)
Liver fibrosis and loss of liver function
– Acute kidney and liver injury
– Highly sensitive & specific biomarker
Liver & kidney injury biomarker Complimentary to α-GST & π-GST
Adiponectin, Proinsulin, & Leptin
Diabetes, metabolic syndrome, endocrine factors
For research use only in the U.S. and Canada
Thank you for making us your
trusted resource for 20 years!
8948 Beckett Rd 45069 West Chester US